CAMBRIDGE, Mass., Aug. 28, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will present a company overview at several upcoming conferences.
* Julian Adams, Ph.D., president of research and development and chief scientific officer, will present at the Newsmakers in the Biotech Industry Conference in New York on September 4, 2008 at 2:00 p.m. EDT. * Steven H. Holtzman, chair, president, and chief executive officer, will present at the R.W. Baird Small-Cap Healthcare Conference in New York on September 10, 2008 at 12:40 p.m. EDT. * Adelene Q. Perkins, executive vice present and chief business officer, will present at the 2008 UBS Global Life Sciences Conference in New York on September 25, 2008 at 8:00 a.m. EDT
A live webcast of each of these presentations will be accessible in the Investor Relations section of the company's website at http://www.infi.com. A replay of each presentation will also be available on the company's website for 30 days from the date of presentation.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to deliver best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.infi.com. INFI-G